Letrozole is a third-generation aromatase inhibitor — a non-steroidal compound that blocks the enzyme converting androgens into estrogens, which is why it sits in the anti-estrogen section rather than among the anabolics.
Alpha Pharma packs it as Letromina: fifty oral tablets carrying 2.5 mg each, the strength this molecule has been registered at for decades. Tablets are small and come on blister strips, so the whole pack takes up almost no room. Within Alpha Pharma's broad human-grade catalogue this is an ancillary item rather than a headline product.
